SCHEMBL7466103

SCHEMBL7466103

CC1(C)COC(CCCCl)=N1

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
HRH3 Q9Y5N1 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8856019 0.87 KDM4E (0.38) KDM4EALDH1A1HTTATMHRH3
SCHEMBL9065677 0.85 KDM4E (0.37) KDM4EALDH1A1HTTATMHRH3
SCHEMBL9066008 0.85 KDM4E (0.37) KDM4EALDH1A1HTTATMHRH3
SCHEMBL3132700 0.83 KDM4E (0.41) KDM4EALDH1A1HTTATMHRH3
SCHEMBL5796273 0.82 KDM4E (0.35) KDM4EALDH1A1HTTATM
SCHEMBL11376925 0.80 KDM4E (0.34) KDM4E
SCHEMBL9787963 0.80 KDM4E (0.34) KDM4E
SCHEMBL4123213 0.79
SCHEMBL10616726 0.78 LPL (0.33) KDM4EALDH1A1
SCHEMBL9788005 0.78 LPL (0.33) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5276035-A Central nervous system disorders; Parkinson's disease; antidepressant and dopaminergic agent NOVO NORDISK A/S (DK) 1994-01-04 US disclosed
EP-0541617-A1 1,4-DISUBSTITUTED PIPERAZINES. NOVO NORDISK AS (DK) 1993-05-19 EP disclosed
WO-1992001679-A1 1,4-DISUBSTITUTED PIPERAZINES NOVO NORDISK A/S (DK) 1992-02-06 WO disclosed